EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, SNGX: Soligenix Inc

12 Nov 25 15:59
LAST:

1.360

CHANGE:
 0.06		OPEN:
1.380		HIGH:
1.440		ASK:
2.010		VOLUME:
107.9K
CHG(%):
4.23		PREV:
1.420		LOW:
1.350		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Nov 251.4101.4401.3501.360118.4K
11 Nov 251.3701.4231.3701.420158.5K
10 Nov 251.4201.4351.3601.360152.8K
07 Nov 251.2901.3901.2501.370271.4K
06 Nov 251.3701.3701.2601.280286.4K
05 Nov 251.3101.3801.3101.380239.7K
04 Nov 251.4401.4701.3001.340696.8K
03 Nov 251.5501.5601.4301.470219.4K
31 Oct 251.5101.5601.4901.550175.1K
30 Oct 251.5501.5701.5101.510247.1K

COMPANY PROFILE

Name:Soligenix Inc
About:Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in Phase 3 clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX945, an IDR technology that is in Phase 2a study to treat aphthous ulcers in Behçet's disease; and SGX302, an IDR technology, which is in Phase 2a study for the treatment of mild-to-moderate psoriasis. Its Public Health Solutions segment engages in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a, 1b, and 1c clinical trials; SGX943, a therapeutic candidate in preclinical studies for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; CiVax, a vaccine candidate for the prevention of COVID-19; and vaccine programs that target filoviruses, such as Marburg and Ebola. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:29 Emmons Drive, Princeton, NJ, United States, 08540
Website:https://www.soligenix.com
CUSIP:834223109
CIK:0000812796
ISIN:US8342233074
FIGI:BBG000FVMHG5
LEI:549300MN2EF9LQHLT817

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.360.1%
MA10:1.403.2%
MA20:1.5010.6%
MA50:1.8435.2%
MA100:2.0147.8%
MA200:2.0550.7%
STO9:28.57
STO14:22.22
RSI14:33.33 
WPR14:-73.33
MTM14:-0.22
ROC14:-0.14 
ATR:0.09 
Week High:1.445.9%
Week Low:1.258.8%
Month High:1.7629.4%
Month Low:1.2550.7%
Year High:6.23358.1%
Year Low:1.0924.8%

RECENT SPLITS

Date Ratio
06 Jun 20241-16
10 Feb 20231-15
07 Oct 20161-10
01 Feb 20121-20
11 Jun 19971-15